Pay in 4 interest-free payments of $7.42 Learn more
Ships within 48 hours · Estimated delivery Nov 6 - Nov 11
Clinical trials demonstrate average weight reductions of approximately 15% with semaglutide 2.4 mg (STEP 1 trial) and 20-22.5% with tirzepatide 10-15 mg (SURMOUNT-1 trial) over 68-72 weeks
This dual action helps maintain glycaemic control
Tirzepatide is particularly potent at managing hunger, ultimately translating to reductions on the scale
What payment methods do Australian research facilities use
It works by mimicking hormones that regulate how your body processes food and sugar
US$ 25.25
US$ 23.35
US$ 23.12
US$ 25.55
US$ 29.19
US$ 26.74
US$ 27.07
